Quintrio
Home

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

eXoZymes Inc. Common Stock

EXOZ

EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.

Last trade $0.00
Day change $0.00 (0.00%)
Day range $3.16 – $3.95
Volume 13,271
Market cap $38M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$37.67M
Price / earnings
—
Price / book
10.31×
Price / sales
—
EV / sales
—
EV / EBITDA
-3.12×

Profitability

Earnings per share
-$1.08
Return on assets
-127.67%
Return on equity
-278.89%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.02×
Current ratio
3.81×
Quick ratio
3.81×
Cash ratio
3.49×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$7.14M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for EXOZ, quarterly periods
Line itemQ2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025
Revenue$0$0$0$0$0$0
Cost of revenue$0$0$0$0$0$0
Gross profit$0$0$0$0$0$0
Selling, general and administrative$1.5M$1.27M$1.58M$1.31M$1.7M$1.38M
Research and development$1.45M$1.12M$1.11M$1.22M$844.83K$575.02K
Total operating expenses$2.95M$2.39M$2.7M$2.52M$2.55M$1.95M
Operating income-$2.95M-$2.39M-$2.7M-$2.52M-$2.55M-$1.95M
Interest expense$0$13.72K$0$0$0$94.31K
Income before taxes-$2.88M-$2.37M-$2.76M-$2.29M-$2.36M-$1.86M
Income taxes$0$0-$105.21K$0$0$0
Net income-$2.88M-$2.37M-$2.66M-$2.29M-$2.36M-$1.86M
Net income attributable to common shareholders-$2.88M-$2.37M-$2.66M-$2.29M-$2.36M-$1.86M
EBITDA-$2.86M-$2.32M-$2.63M-$2.46M-$2.46M-$1.89M
Basic earnings per share-$0.33-$0.28-$0.32-$0.27-$0.28-$0.22
Diluted earnings per share-$0.33-$0.28-$0.32-$0.27-$0.28-$0.22

Recent news

Company coverage with links to the original publishers.

Publication times in UTC

No recent company news found.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.